CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 22 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $225,000 | -75.7% | 12,249 | -76.8% | 0.00% | – |
| Q1 2018 | $927,000 | +71.7% | 52,843 | -14.4% | 0.00% | – |
| Q2 2017 | $540,000 | +141.1% | 61,733 | +230.1% | 0.00% | – |
| Q2 2016 | $224,000 | +47.4% | 18,703 | +58.5% | 0.00% | – |
| Q4 2014 | $152,000 | -63.9% | 11,798 | -41.2% | 0.00% | – |
| Q3 2014 | $421,000 | – | 20,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|